Details for Patent: 8,207,149
✉ Email this page to a colleague
Which drugs does patent 8,207,149 protect, and when does it expire?
Patent 8,207,149 protects RAYALDEE and is included in one NDA.
This patent has fifty-three patent family members in sixteen countries.
Summary for Patent: 8,207,149
| Title: | Method for treating secondary hyperparathyroidism in CKD |
| Abstract: | A stable, controlled release formulation for oral dosing of vitamin D compounds is disclosed. The formulation is prepared by incorporating one or more vitamin D compounds into a solid or semi-solid mixture of waxy materials. Oral dosage forms can be prepared by melt-blending the components described herein and filling gelatin capsules with the formulation. |
| Inventor(s): | Tabash; Samir P. (Whitby, CA), White; Jay A. (Newmarket, CA), Bishop; Charles W. (Mount Horeb, WI), Agudoawu; Sammy A. (Mississauga, CA), Messner; Eric J. (Lake Forest, IL), Petkovich; P. Martin (Kingston, CA) |
| Assignee: | Cytochroma, Inc. (Markham, CA) Proventiv Therapeutics, LLC (Bannockburn, IL) |
| Application Number: | 13/244,945 |
|
Patent Claim Types: see list of patent claims | Use; Dosage form; |
Drugs Protected by US Patent 8,207,149
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eirgen | RAYALDEE | calcifediol | CAPSULE, EXTENDED RELEASE;ORAL | 208010-001 | Jun 17, 2016 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS WITH STAGE 3 OR 4 CHRONIC KIDNEY DISEASE USING CONTROLLED RELEASE, ORAL 25-HYDROXYVITAMIN D | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,207,149
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2481400 | ⤷ Sign Up | 301085 | Netherlands | ⤷ Sign Up |
| European Patent Office | 2481400 | ⤷ Sign Up | 122020000079 | Germany | ⤷ Sign Up |
| European Patent Office | 2481400 | ⤷ Sign Up | CA 2020 00059 | Denmark | ⤷ Sign Up |
| European Patent Office | 2481400 | ⤷ Sign Up | C02481400/01 | Switzerland | ⤷ Sign Up |
| European Patent Office | 2481400 | ⤷ Sign Up | 132021000000071 | Italy | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
